Wnt(beta)-catenin

Wnt(beta)-catenin

A protein with two distinct functions, -catenin controls both the coordination of gene transcription and cell-cell adhesion. The CTNNB1 gene in humans encodes the CTNNB1 protein. In the Wnt signaling pathway, -catenin functions as an intracellular signal transducer as a subunit of the cadherin protein complex.It is a homolog of -catenin and a member of the catenin protein family. Hepatocellular carcinoma, colorectal carcinoma, lung cancer, malignant breast tumors, ovarian, and endometrial cancer are just a few of the cancers that have been linked to mutations and overexpression of -catenin. The beta-catenin destruction complex, and in particular the adenomatous polyposis coli (APC) protein, which is encoded by the tumor-suppressing APC gene, regulates and annihilates -catenin. As a result, genetic APC gene mutation is strongly associated with cancers, particularly colorectal cancer brought on by familial adenomatous polyposis (FAP).

Wnt(beta)-catenin related products

Structure Cat No. Product Name CAS No. Product Description
V26036 MSAB 173436-66-3 MSAB is a novel and potent inhibitor of Wnt/β-catenin signaling withanticancer activity.
V51041 N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide 883715-23-9 N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide is a macamide extracted from Maca (Lepidium meyenii Walp).
V3200 NCB-0846 1792999-26-8 NCB-0846 (NCB0846) is a novel, first orally bioavailable small molecule inhibitor of Wntthat inhibitsTNIK (TRAF2 and NCK-Interacting Kinase)with IC50 value of 21 nM.
V27702 PNU-74654 113906-27-7 PNU-74654 (PNU74654) is a novel inhibitor of Wnt/β-catenin pathway (IC50 = 129.8 μM), acting byinhibiting the interaction between ß-catenin and T cell factor 4 (Tcf4), and disrupting the Wnt signaling pathway.
V2690 PRI-724 1422253-38-0 PRI-724 (an analog of ICG 001 and a prodrug of C-82)is a novel, potent an specific inhibitor of the canonical Wnt signaling pathway in cancer stem cells with potential antineoplastic activity.
V7131 Prinaberel (ERB041) 524684-52-4 Prinaberel, formerly known as ERB-041, is a biochemical which acts as a highly selective agonist of the ERβ subtype of the estrogen receptor.
V51023 Prodigiosin HCl 56144-17-3 Prodigiosin (Prodigiosine) HCl, a natural red pigment, is a biologically active secondary metabolite (SM, chemical compound).
V4111 Pyrvinium 3546-41-6 Pyrvinium is an FDA-approved antihelmintic drugfor pinworms, it inhibitsWNTpathway signaling.
V12294 RCM-1 339163-65-4 RCM-1 is a novel and potent nontoxic FOXM1 inhibitor, which is able to inhibit goblet cell metaplasia and excessive mucus production.
V1861 Salinomycin (Procoxacin) 53003-10-4 Salinomycin (also known as AHR-3096, or Procoxacin) is a potent antibacterial and coccidiostat ionophore therapeutic agent with potential anticancer activities by targeting stem cells.
V7468 SKL2001 free base 909089-13-0 SKL2001 (SKL-2001) is a novel and potent agonist of Wnt/β-catenin signaling pathway with antitumor activity.
V37621 SM04554 (Dalosirvat) 1360540-81-3 SM04554(Dalosirvat, Wnt pathway activator 1), a novel activator of Wnt with an IC50s of 28-29 nM,is an experimental drug that shows promise for treating androgenetic alopecia (male pattern baldness).
V16012 Tegatrabetan (BC2059) 1227637-23-1 Tegatrabetan(also known as Tegavivint; BC-2059; BC 2059;BC2059) is an orally bioavailable and potent β-catenin inhibitor with potential anticancer activity.
V51026 Teplinovivint 1428064-91-8 Teplinovivint is a potent inhibitor of the wnt/β-catenin signaling pathway.
V3007 WAY-262611 1123231-07-1 WAY-262611 (WAY262611) is a novel agonist of the wingless β-Catenin pathway with the potential forthe treatment of bone disorders.
V51018 Wnt/β-catenin agonist 2 943820-93-7 Wnt/β-catenin agonist 2 is a potent Wnt agonist.
V51019 Wnt/β-catenin agonist 4 912784-79-3 Wnt/β-catenin agonist 4 (analogue 83) is a Wnt agonist that activates/agonizes Wnt/β-catenin signaling.
Contact Us Back to top